697 related articles for article (PubMed ID: 26470536)
21. Vaccines against 'the other' Ebolavirus species.
Kozak RA; Kobinger GP
Expert Rev Vaccines; 2016 Sep; 15(9):1093-100. PubMed ID: 27010528
[TBL] [Abstract][Full Text] [Related]
22. Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases.
Tully CM; Lambe T; Gilbert SC; Hill AV
Lancet Infect Dis; 2015 Mar; 15(3):356-9. PubMed ID: 25595637
[TBL] [Abstract][Full Text] [Related]
23. Adenovirus-vectored Ebola vaccines.
Gilbert SC
Expert Rev Vaccines; 2015; 14(10):1347-57. PubMed ID: 26289977
[TBL] [Abstract][Full Text] [Related]
24. Viral infections: New options to fight Ebola.
Nunes-Alves C
Nat Rev Drug Discov; 2015 Jun; 14(6):385. PubMed ID: 26027535
[No Abstract] [Full Text] [Related]
25. Guns N' viruses.
Häfner S
Microbes Infect; 2019; 21(3-4):125-128. PubMed ID: 30684684
[No Abstract] [Full Text] [Related]
26. Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.
Milligan ID; Gibani MM; Sewell R; Clutterbuck EA; Campbell D; Plested E; Nuthall E; Voysey M; Silva-Reyes L; McElrath MJ; De Rosa SC; Frahm N; Cohen KW; Shukarev G; Orzabal N; van Duijnhoven W; Truyers C; Bachmayer N; Splinter D; Samy N; Pau MG; Schuitemaker H; Luhn K; Callendret B; Van Hoof J; Douoguih M; Ewer K; Angus B; Pollard AJ; Snape MD
JAMA; 2016 Apr; 315(15):1610-23. PubMed ID: 27092831
[TBL] [Abstract][Full Text] [Related]
27. A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus.
Tsuda Y; Caposio P; Parkins CJ; Botto S; Messaoudi I; Cicin-Sain L; Feldmann H; Jarvis MA
PLoS Negl Trop Dis; 2011 Aug; 5(8):e1275. PubMed ID: 21858240
[TBL] [Abstract][Full Text] [Related]
28. Translational success of fundamental virology: a VSV-vectored Ebola vaccine.
Anderson EM; Coller B-AG
J Virol; 2024 Mar; 98(3):e0162723. PubMed ID: 38305150
[TBL] [Abstract][Full Text] [Related]
29. Ebola vaccines in clinical trial: The promising candidates.
Wang Y; Li J; Hu Y; Liang Q; Wei M; Zhu F
Hum Vaccin Immunother; 2017 Jan; 13(1):153-168. PubMed ID: 27764560
[TBL] [Abstract][Full Text] [Related]
30. Will There Be a Cure for Ebola?
Cardile AP; Warren TK; Martins KA; Reisler RB; Bavari S
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():329-348. PubMed ID: 27959624
[TBL] [Abstract][Full Text] [Related]
31. Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.
Agnandji ST; Huttner A; Zinser ME; Njuguna P; Dahlke C; Fernandes JF; Yerly S; Dayer JA; Kraehling V; Kasonta R; Adegnika AA; Altfeld M; Auderset F; Bache EB; Biedenkopf N; Borregaard S; Brosnahan JS; Burrow R; Combescure C; Desmeules J; Eickmann M; Fehling SK; Finckh A; Goncalves AR; Grobusch MP; Hooper J; Jambrecina A; Kabwende AL; Kaya G; Kimani D; Lell B; Lemaître B; Lohse AW; Massinga-Loembe M; Matthey A; Mordmüller B; Nolting A; Ogwang C; Ramharter M; Schmidt-Chanasit J; Schmiedel S; Silvera P; Stahl FR; Staines HM; Strecker T; Stubbe HC; Tsofa B; Zaki S; Fast P; Moorthy V; Kaiser L; Krishna S; Becker S; Kieny MP; Bejon P; Kremsner PG; Addo MM; Siegrist CA
N Engl J Med; 2016 Apr; 374(17):1647-60. PubMed ID: 25830326
[TBL] [Abstract][Full Text] [Related]
32. Small molecule inhibitors of ebola virus infection.
Picazo E; Giordanetto F
Drug Discov Today; 2015 Feb; 20(2):277-86. PubMed ID: 25532798
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of Vesicular Stomatitis Virus-Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona.
Marzi A; Hanley PW; Haddock E; Martellaro C; Kobinger G; Feldmann H
J Infect Dis; 2016 Oct; 214(suppl 3):S360-S366. PubMed ID: 27496978
[TBL] [Abstract][Full Text] [Related]
34. Development of vaccines for prevention of Ebola virus infection.
Ye L; Yang C
Microbes Infect; 2015 Feb; 17(2):98-108. PubMed ID: 25526819
[TBL] [Abstract][Full Text] [Related]
35. Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine.
Zhou Y; Sullivan NJ
Curr Opin Immunol; 2015 Aug; 35():131-6. PubMed ID: 26247875
[TBL] [Abstract][Full Text] [Related]
36. Risk of Misinterpretation of Ebola Virus PCR Results After rVSV ZEBOV-GP Vaccination.
Cnops L; Gerard M; Vandenberg O; Van den Wijngaert S; Heyndrickx L; Willems E; Demeulemeester K; De Clerck H; Dediste A; Callens S; De Munter P; Vlieghe E; Bottieau E; Wuillaume F; Van Esbroeck M; Ariën KK
Clin Infect Dis; 2015 Jun; 60(11):1725-6. PubMed ID: 25694650
[No Abstract] [Full Text] [Related]
37. Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge.
Stanley DA; Honko AN; Asiedu C; Trefry JC; Lau-Kilby AW; Johnson JC; Hensley L; Ammendola V; Abbate A; Grazioli F; Foulds KE; Cheng C; Wang L; Donaldson MM; Colloca S; Folgori A; Roederer M; Nabel GJ; Mascola J; Nicosia A; Cortese R; Koup RA; Sullivan NJ
Nat Med; 2014 Oct; 20(10):1126-9. PubMed ID: 25194571
[TBL] [Abstract][Full Text] [Related]
38. Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector.
Pratt WD; Wang D; Nichols DK; Luo M; Woraratanadharm J; Dye JM; Holman DH; Dong JY
Clin Vaccine Immunol; 2010 Apr; 17(4):572-81. PubMed ID: 20181765
[TBL] [Abstract][Full Text] [Related]
39. Experimental drugs poised for use in Ebola outbreak.
Check Hayden E
Nature; 2018 May; 557(7706):475-476. PubMed ID: 29789732
[No Abstract] [Full Text] [Related]
40. Ebola and ethics.
Griffiths PD
Rev Med Virol; 2014 Nov; 24(6):363-4. PubMed ID: 25318448
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
